BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28489007)

  • 1. [Frequency of symptoms and drug treatment among dying patients in the last 24 hours of life at Landspitali - The National University Hospital of Iceland and in nursing homes].
    Halfdanardottir SI; Olafsdottir KL; Sigurdardottir V
    Laeknabladid; 2017 Mai; 103(5):223-228. PubMed ID: 28489007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?
    Gambles M; McGlinchey T; Latten R; Dickman A; Lowe D; Ellershaw JE
    BMJ Support Palliat Care; 2011 Dec; 1(3):329-33. PubMed ID: 24653479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dying with dementia: symptoms, treatment, and quality of life in the last week of life.
    Hendriks SA; Smalbrugge M; Hertogh CM; van der Steen JT
    J Pain Symptom Manage; 2014 Apr; 47(4):710-20. PubMed ID: 23916680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of midazolam and haloperidol in cancer patients at the end of life.
    Radha Krishna LK; Poulose VJ; Goh C
    Singapore Med J; 2012 Jan; 53(1):62-6. PubMed ID: 22252186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological management of pain in Australian Aged Care Facilities.
    Veal FC; Bereznicki LR; Thompson AJ; Peterson GM
    Age Ageing; 2014 Nov; 43(6):851-6. PubMed ID: 24927723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion.
    Lindqvist O; Lundquist G; Dickman A; Bükki J; Lunder U; Hagelin CL; Rasmussen BH; Sauter S; Tishelman C; Fürst CJ;
    J Palliat Med; 2013 Jan; 16(1):38-43. PubMed ID: 23234300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective medical records review of risk factors for the development of respiratory tract secretions (death rattle) in the dying patient.
    Kolb H; Snowden A; Stevens E; Atherton I
    J Adv Nurs; 2018 Jul; 74(7):1639-1648. PubMed ID: 29741782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drugs for terminally ill patients with respiratory disease.
    Kanemoto K; Satoh H; Kagohashi K; Kurishima K; Ishikawa H; Ohtsuka M
    Tuberk Toraks; 2007; 55(1):5-10. PubMed ID: 17401788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From admission to death: prevalence and course of pain, agitation, and shortness of breath, and treatment of these symptoms in nursing home residents with dementia.
    Hendriks SA; Smalbrugge M; Galindo-Garre F; Hertogh CM; van der Steen JT
    J Am Med Dir Assoc; 2015 Jun; 16(6):475-81. PubMed ID: 25736822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine-fentanyl-midazolam infusion for the control of symptoms in terminal life care.
    Berger JM; Ryan A; Vadivelu N; Merriam P; Rever L; Harrison P
    Am J Hosp Palliat Care; 2000; 17(2):127-34. PubMed ID: 11406957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medication use in nursing homes in Iceland 2002-2004. A descriptive study].
    Hansdóttir H; Guđmannsson PG
    Laeknabladid; 2013 Sep; 99(9):383-9. PubMed ID: 24077515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain as a challenge in nursing home residents with behavioral and psychological symptoms of dementia.
    Nowak T; Neumann-Podczaska A; Deskur-Śmielecka E; Styszyński A; Wieczorowska-Tobis K
    Clin Interv Aging; 2018; 13():1045-1051. PubMed ID: 29872283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of systematic evaluation of pain and agitation in an intensive care unit.
    Chanques G; Jaber S; Barbotte E; Violet S; Sebbane M; Perrigault PF; Mann C; Lefrant JY; Eledjam JJ
    Crit Care Med; 2006 Jun; 34(6):1691-9. PubMed ID: 16625136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The last 48 hours of life in long-term care: a focused chart audit.
    Hall P; Schroder C; Weaver L
    J Am Geriatr Soc; 2002 Mar; 50(3):501-6. PubMed ID: 11943047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Protocol for the Control of Agitation in Palliative Care.
    Gonçalves F; Almeida A; Pereira S
    Am J Hosp Palliat Care; 2016 Dec; 33(10):948-951. PubMed ID: 26273093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of intolerable sufferings in a hospice unit].
    Rosland JH; Saunes TK; Bull AN
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2661-4. PubMed ID: 17952148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Palliative care for patients with COPD: a challenge].
    du Couëdic L; Morel V; Trehello L; Trehony A; Robert M; Sandron D
    Rev Mal Respir; 2012 Nov; 29(9):1088-94. PubMed ID: 23200580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ketamine, fentanyl, and midazolam infusion for uncontrolled terminal pain and agitation.
    Enck RE
    Am J Hosp Palliat Care; 2000; 17(2):76-7. PubMed ID: 11406960
    [No Abstract]   [Full Text] [Related]  

  • 19. A tertiary hospital audit of opioids and sedatives administered in the last 24 h of life.
    Douglas C; Clarke M; Alexander S; Khatun M
    Intern Med J; 2016 Mar; 46(3):325-31. PubMed ID: 26691911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain and Agitation Management in Critically Ill Patients.
    Stephens J; Wright M
    Nurs Clin North Am; 2016 Mar; 51(1):95-106. PubMed ID: 26897427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.